Leonardo Drs, Inc. (DRS)

$28.5

+0.33

(+1.17%)▲

Market is closed - opens 7 PM, 29 Jul 2024

Performance

  • $28.29
    $28.62
    $28.50
    downward going graph

    0.74%

    Downside

    Day's Volatility :1.14%

    Upside

    0.4%

    downward going graph
  • $15.75
    $29.64
    $28.50
    downward going graph

    44.74%

    Downside

    52 Weeks Volatility :46.86%

    Upside

    3.85%

    downward going graph

Returns

PeriodLeonardo Drs, Inc.Index (Russel 2000)
3 Months
30.0%
0.0%
6 Months
43.87%
0.0%
1 Year
66.39%
0.0%
3 Years
156.32%
-20.2%

Highlights

Market Capitalization
7.3B
Book Value
$8.96
Earnings Per Share (EPS)
0.7
PE Ratio
39.7
Wall Street Target Price
26.71
Profit Margin
6.28%
Operating Margin TTM
6.25%
Return On Assets TTM
4.36%
Return On Equity TTM
8.23%
Revenue TTM
2.9B
Revenue Per Share TTM
11.23
Quarterly Revenue Growth YOY
20.9%
Gross Profit TTM
575.0M
EBITDA
345.0M
Diluted Eps TTM
0.7
Quarterly Earnings Growth YOY
1.38
EPS Estimate Current Year
0.81
EPS Estimate Next Year
0.97
EPS Estimate Current Quarter
0.11
EPS Estimate Next Quarter
0.15

Analyst Recommendation

Buy
    80%Buy
    20%Hold
    0
    0%Sell
Based on 10 Wall street analysts offering stock ratings for Leonardo Drs, Inc.(by analysts ranked 0 to 5 stars)
Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
8
Hold
2
2
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Downside of 6.28%

Current $28.50
Target $26.71

Company Financials

FY18Y/Y Change
Revenue
2.3B
↑ 8810.7%
Net Income
-10.0M
↓ 546.63%
Net Profit Margin
-0.43%
↓ 8.98%
FY19Y/Y Change
Revenue
2.7B
↑ 16.33%
Net Income
75.0M
↓ 850.0%
Net Profit Margin
2.76%
↑ 3.19%
FY20Y/Y Change
Revenue
2.8B
↑ 2.36%
Net Income
85.0M
↑ 13.33%
Net Profit Margin
3.06%
↑ 0.3%
FY21Y/Y Change
Revenue
2.9B
↑ 3.64%
Net Income
154.0M
↑ 81.18%
Net Profit Margin
5.35%
↑ 2.29%
FY22Y/Y Change
Revenue
2.7B
↓ 6.46%
Net Income
405.0M
↑ 162.99%
Net Profit Margin
15.04%
↑ 9.69%
FY23Y/Y Change
Revenue
2.8B
↑ 4.94%
Net Income
168.0M
↓ 58.52%
Net Profit Margin
5.94%
↓ 9.1%
Q4 FY22Q/Q Change
Revenue
820.0M
↑ 29.34%
Net Income
65.0M
↓ 76.7%
Net Profit Margin
7.93%
↓ 36.08%
Q1 FY23Q/Q Change
Revenue
569.0M
↓ 30.61%
Net Income
12.0M
↓ 81.54%
Net Profit Margin
2.11%
↓ 5.82%
Q2 FY23Q/Q Change
Revenue
628.0M
↑ 10.37%
Net Income
35.0M
↑ 191.67%
Net Profit Margin
5.57%
↑ 3.46%
Q3 FY23Q/Q Change
Revenue
703.0M
↑ 11.94%
Net Income
47.0M
↑ 34.29%
Net Profit Margin
6.69%
↑ 1.12%
Q4 FY23Q/Q Change
Revenue
926.0M
↑ 31.72%
Net Income
74.0M
↑ 57.45%
Net Profit Margin
7.99%
↑ 1.3%
Q1 FY24Q/Q Change
Revenue
688.0M
↓ 25.7%
Net Income
29.0M
↓ 60.81%
Net Profit Margin
4.22%
↓ 3.77%
FY18Y/Y Change
Total Assets
53.5M
↑ 48.49%
Total Liabilities
11.3M
↑ 50.44%
FY19Y/Y Change
Total Assets
2.9B
↑ 5297.93%
Total Liabilities
1.9B
↑ 16455.94%
FY20Y/Y Change
Total Assets
3.0B
↑ 2.35%
Total Liabilities
1.5B
↓ 18.19%
FY21Y/Y Change
Total Assets
3.1B
↑ 3.82%
Total Liabilities
1.5B
↓ 3.47%
FY22Y/Y Change
Total Assets
3.7B
↑ 19.81%
Total Liabilities
1.6B
↑ 5.01%
FY23Y/Y Change
Total Assets
4.0B
↑ 9.84%
Total Liabilities
1.7B
↑ 10.58%
Q4 FY22Q/Q Change
Total Assets
3.7B
↑ 25.45%
Total Liabilities
1.6B
↑ 11.27%
Q1 FY23Q/Q Change
Total Assets
3.7B
↑ 0.11%
Total Liabilities
1.5B
↓ 0.77%
Q2 FY23Q/Q Change
Total Assets
3.7B
↓ 0.52%
Total Liabilities
1.5B
↓ 4.23%
Q3 FY23Q/Q Change
Total Assets
3.7B
↑ 1.39%
Total Liabilities
1.5B
↓ 0.14%
Q4 FY23Q/Q Change
Total Assets
4.0B
↑ 8.78%
Total Liabilities
1.7B
↑ 16.52%
Q1 FY24Q/Q Change
Total Assets
3.8B
↓ 6.39%
Total Liabilities
1.4B
↓ 16.8%
FY18Y/Y Change
Operating Cash Flow
105.0M
↑ 9640.26%
Investing Cash Flow
-46.0M
↑ 2312.17%
Financing Cash Flow
-30.0M
↓ 365.67%
FY19Y/Y Change
Operating Cash Flow
157.0M
↑ 49.52%
Investing Cash Flow
-151.0M
↑ 228.26%
Financing Cash Flow
-1000.0K
↓ 96.67%
FY20Y/Y Change
Operating Cash Flow
125.0M
↓ 20.38%
Investing Cash Flow
-70.0M
↓ 53.64%
Financing Cash Flow
-80.0M
↑ 7900.0%
FY21Y/Y Change
Operating Cash Flow
178.0M
↑ 42.4%
Investing Cash Flow
39.0M
↓ 155.71%
Financing Cash Flow
-38.0M
↓ 52.5%
FY22Y/Y Change
Operating Cash Flow
33.0M
↓ 81.46%
Investing Cash Flow
436.0M
↑ 1017.95%
Financing Cash Flow
-403.0M
↑ 960.53%
Q4 FY22Q/Q Change
Operating Cash Flow
279.0M
↓ 7075.0%
Investing Cash Flow
436.0M
↓ 7.23%
Financing Cash Flow
-24.0M
↓ 94.92%
Q1 FY23Q/Q Change
Operating Cash Flow
-334.0M
↓ 219.71%
Investing Cash Flow
-14.0M
↓ 103.21%
Financing Cash Flow
216.0M
↓ 1000.0%
Q2 FY23Q/Q Change
Operating Cash Flow
-12.0M
↓ 96.41%
Investing Cash Flow
-12.0M
↓ 14.29%
Financing Cash Flow
-115.0M
↓ 153.24%
Q3 FY23Q/Q Change
Operating Cash Flow
36.0M
↓ 400.0%
Investing Cash Flow
-42.0M
↑ 250.0%
Financing Cash Flow
-8.0M
↓ 93.04%

Technicals Summary

Sell

Neutral

Buy

Leonardo Drs, Inc. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Leonardo Drs, Inc.
Leonardo Drs, Inc.
8.6%
43.87%
66.39%
156.32%
156.32%
Rtx Corp
Rtx Corp
12.06%
25.51%
31.48%
32.02%
-16.34%
Boeing Company, The
Boeing Company, The
3.28%
-10.28%
-20.81%
-18.38%
-46.57%
Lockheed Martin Corporation
Lockheed Martin Corporation
11.65%
21.28%
15.15%
41.67%
41.12%
General Dynamics Corporation
General Dynamics Corporation
-1.21%
9.77%
30.61%
51.62%
53.37%
General Electric Company
General Electric Company
2.51%
57.28%
43.54%
59.32%
95.85%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Leonardo Drs, Inc.
Leonardo Drs, Inc.
39.7
39.7
NA
0.81
0.08
0.04
NA
8.96
Rtx Corp
Rtx Corp
41.27
41.27
0.86
4.95
0.05
0.02
0.02
45.5
Boeing Company, The
Boeing Company, The
58.37
NA
6.53
-2.29
0.0
0.0
NA
-27.73
Lockheed Martin Corporation
Lockheed Martin Corporation
18.69
18.69
4.78
24.3
0.87
0.1
0.02
26.06
General Dynamics Corporation
General Dynamics Corporation
22.72
22.72
1.75
14.53
0.17
0.05
0.02
80.33
General Electric Company
General Electric Company
43.86
43.86
2.03
3.74
0.16
0.03
0.01
17.15
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Leonardo Drs, Inc.
Leonardo Drs, Inc.
Buy
$7.3B
156.32%
39.7
6.28%
Rtx Corp
Rtx Corp
Hold
$139.4B
-16.34%
41.27
4.9%
Boeing Company, The
Boeing Company, The
Buy
$110.5B
-46.57%
58.37
-2.81%
Lockheed Martin Corporation
Lockheed Martin Corporation
Hold
$124.3B
41.12%
18.69
9.48%
General Dynamics Corporation
General Dynamics Corporation
Buy
$80.0B
53.37%
22.72
7.89%
General Electric Company
General Electric Company
Buy
$176.0B
95.85%
43.86
6.84%

Insights on Leonardo Drs, Inc.

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 926.0M → 688.0M (in $), with an average decrease of 25.7% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 74.0M → 29.0M (in $), with an average decrease of 60.8% per quarter

Company Information

leonardo drs is a prime contractor, leading technology innovator and supplier of integrated products, services and support to military forces, intelligence agencies and defense contractors worldwide. the company specializes in naval and maritime systems, ground combat mission command and network computing, global satellite communications and network infrastructure, avionics systems, and intelligence and security solutions. additionally, the company builds power systems and electro-optical/infrared systems for a wide range of commercial customers. headquartered in arlington, virginia, leonardo drs is a wholly owned subsidiary of leonardo s.p.a., which employs more than 47,000 people worldwide. see the full range of capabilities at www.leonardodrs.com and on twitter @drstechnologies.

Organization
Leonardo Drs, Inc.
Employees
6600
CEO
Mr. William J. Lynn III
Industry
Industrials

Discover More

FAQs